These different effects on proliferation are confirmed by the fact that the syngeneic CML-like disease induced by BCR/ABL-T315I is significantly delayed as compared to that induced by native BCR/ABL [6]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.